Animal & Veterinary Recalls
Mid America Pet Food Issues Voluntary Recall Due to Possible Salmonella Health Risk
Mid America Pet Food, Mount Pleasant, Texas, is voluntarily recalling one lot of Victor Super Premium Dog Food, Hi-Pro Plus produced at its Mount Pleasant, Texas production facility because it has the potential to be contaminated with Salmonella. Salmonella can affect animals eating the products and there is risk to humans from handling contaminated pet products, especially if they have not thoroughly washed their hands after having contact with the products or any surfaces exposed to these products.
Healthy people infected with Salmonella should monitor themselves for some or all of the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping and fever. Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms. Consumers exhibiting these signs after having contact with this product should contact their healthcare providers.
Pets with Salmonella infections may be lethargic and have diarrhea or bloody diarrhea, fever, and vomiting. Some pets will have only decreased appetite, fever and abdominal pain. Infected but otherwise healthy pets can be carriers and infect other animals or humans. If your pet has consumed the recalled product and has these symptoms, please contact your veterinarian.
The affected product was only sold in 5-pound bags. No human or pet illnesses have been reported to date.
Products were distributed to various distributors and retailers in the United States. The affected product consists of 644 cases sold in 5-pound bags with lot code 1000016385 with Best By Date 4/30/2024.
Merck Animal Health Issues Voluntary Recall for Three Lots of BANAMINE® / BANAMINE®-S (Flunixin Meglumine Injection) in the U.S., Due to Presence of Particulate Matter
RAHWAY, N.J., Sept. 1, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA. (NYSE:MRK), is voluntarily recalling three batches of BANAMINE®/BANAMINE®-S (flunixin meglumine injection) 50 mg/mL in the United States, used for injection in cattle, swine and horses to the consumer level due to the presence of particulate matter. BANAMINE® /BANAMINE®-S (flunixin meglumine injection) is a prescription product in the U.S.
Particulates were observed during routine quality testing and reviews for the following batches:
- BANAMINE 100mL, UIN 065474, NDC 00061-0851-03, Batch 2834102, exp Oct. 2024
o Distribution dates: March 6, 2023, to May 3, 2023
- BANAMINE 250mL, UIN 065476, NDC 00061-0851-04, Batch 2864102, exp Nov. 2024
o Distribution dates: June 21, 2023, to July 11, 2023
- BANAMINE-S 100mL, UIN 065477, NDC 0061-1838-30, Batch 2834103, exp Oct. 2024
o Distribution dates: March 20, 2023, to May 16, 2023
Drug Recalls
WEFUN Inc Issues Voluntary Nationwide Recall of WEFUN Capsules Due to Presence of Undeclared Sildenafil
FOR IMMEDIATE RELEASE – 08/25/2023 – Brooklyn, New York, WEFUN Inc is voluntarily recalling 300 Boxes of WEFUN Capsules to the consumer level. FDA analysis has found the product to be tainted with sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) inhibitor found in FDA-approved products for the treatment of male erectile dysfunction. The presence of sildenafil in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall.
Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up
FOR IMMEDIATE RELEASE – August 30, 2023 – New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label Mix-Up. Bottles of Digoxin Tablets, USP 0.125mg s are incorrectly labeled and contain Digoxin Tablets USP, 0.25mg Tablets. Bottles of Digoxin Tablets USP, 0.25mg are incorrectly labeled and contain Digoxin Tablets USP, 0.125mg.
Digoxin Tablets USP, 0.125mg are yellow, circular, beveled, uncoated tablets scored between "N" and "201" on one side and plain on the other side.
Digoxin Tablets USP, 0.25mg are white to off-white, circular. beveled, uncoated tablets scored between "N" and "202" on one side and plain on the other side.
Food & Beverage Recalls
Weis Markets Issues an Allergy Alert for Weis Quality Premium Brownie Moose Tracks Ice Cream Due to Undeclared Egg Allergen
Sunbury, PA (AUGUST 31, 2023) – Weis Markets Inc. of Sunbury, PA today said it is recalling containers of Weis Quality Brownie Moose Tracks Ice Cream (48oz) because the product may contain undeclared EGG. People who have an allergy or severe sensitivity to EGG run the risk of serious or life-threatening allergic reactions if they consume this product.
Product was distributed to all 197 Weis Markets’ retail stores in Pennsylvania, Maryland, Virginia, New Jersey, New York, Delaware and West Virginia.
The ice cream is packaged in a round container with a UPC of 041497-01194. All sell by dates are included in the recall as a precaution. Sell by dates are located on the bottom of the container.
Medical Device Recalls
Universal Meditech Inc. Issues Nationwide Recall of All Products Manufactured Between March 2021 and November 2022
On July 1, 2023, Universal Meditech Inc. initiated a nationwide recall of products it manufactured between March 2021 and November 2022. The recall is due to the reasons that:
- The company is going out of business, hence would not be able to continue fulfilling any post-market responsibilities of these distributed products.
- Three of the products (PrestiBio Breastmilk Alcohol Test Strip, PrestiBio™ Ketone Test Strips and HealthyWiser KetoFast™ Ketone Test Strips) has been violatively distributed without appropriate premarket clearance or approval which potentially could result in inaccurate test results due to lack of performance evaluation by the FDA.
Consumers who still have unused tests manufactured by Universal Meditech Inc. (please refer to product identifications below) should stop using the device immediately and:
- discard any remaining stock in the trash
- or ship back to Universal Meditech at our expense (please contact us for the courier account information).
Recalled products were manufactured and distributed from March 2021 to November 2022.
Read Comments